Theseus Pharmaceuticals, Inc.
Total Trades
13
Buys
13
Sells
0
Largest Trade
$1M+
Insiders
6
Institutional Funds
2
Inst. Value
$15K–$50K
Activist Filings
16
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| GORDON CARL L | Director | BUY | $1M+ | 480K | $3.05 | Jul 19, 2023 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 480K | $3.05 | Jul 19, 2023 |
| Foresite Capital Management V, LLC | 10% Owner | BUY | $1M+ | 700K | $2.97 | Jul 19, 2023 |
| Foresite Capital Management V, LLC | 10% Owner | BUY | $1M+ | 500K | $5.00 | Jan 3, 2023 |
| HAYDEN DONALD J JR | Director | BUY | $15K–$50K | 10K | $5.00 | Jan 3, 2023 |
| Dahms Bradford D. | CFO | BUY | $1K–$15K | 2K | $6.66 | Dec 1, 2022 |
| CLACKSON TIMOTHY P | President and CEO | BUY | $15K–$50K | 3K | $6.80 | Nov 14, 2022 |
| GORDON CARL L | Director | BUY | $1M+ | 192K | $5.21 | Nov 9, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 192K | $5.21 | Nov 9, 2022 |
| GORDON CARL L | Director | BUY | $1M+ | 158K | $9.97 | Jan 22, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 158K | $9.97 | Jan 22, 2022 |
| GORDON CARL L | Director | BUY | $100K–$500K | 45K | $9.90 | Jan 14, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $100K–$500K | 45K | $9.90 | Jan 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2023 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 10K | $15K–$50K | SH |
| Legal & General Group Plc | 2K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Feb 16, 2024
100.0%
100 shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13G/A · Feb 13, 2024
0 shares
SC 13D/A · Jan 12, 2024
7.3%
3.3M shares
SC 13D/A · Dec 28, 2023
7.3%
3.3M shares
SC 13D/A · Dec 27, 2023
40.1%
17.7M shares
SC 13D/A · Nov 24, 2023
40.1%
17.7M shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13D/A · Nov 24, 2023
9.3%
4.1M shares
SC 13D · Nov 24, 2023
7.0%
3.1M shares
SC 13G/A · Aug 10, 2023
0.0%
1K shares
SC 13D/A · Jul 19, 2023
40.7%
17.7M shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13D/A · Jul 19, 2023
9.4%
4.1M shares
SC 13D/A · Mar 14, 2023
39.6%
17.2M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · Jan 23, 2023
2.3%
908K shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13D/A · Jan 3, 2023
9.3%
3.6M shares
SC 13G/A · Dec 12, 2022
8.2%
3.2M shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13D/A · Jun 13, 2022
8.6%
3.3M shares